CVS Health Q2 Revenue Hits $106.1B Beating Analyst Estimates

Key Facts

1CVS Health reported Q2 2026 revenue of $106.10 billion, representing a 7.30% year-over-year increase.

2Adjusted earnings per share reached $2.58, exceeding analyst consensus estimates.

3The company raised its full-year adjusted earnings and cash flow guidance.

CVS Health reported Q2 2026 revenue of $106.10 billion, representing a 7.30% year-over-year increase, according to AD HOC NEWS. Adjusted earnings per share reached $2.58, exceeding the analyst consensus estimate of $1.87. Following these results, the company raised its full-year adjusted earnings and cash flow guidance.

CVS closed at $85.69 on September 30, 2026, with the stock trading between a day low of $85.42 and a high of $87.44 during that session. The updated outlook includes raising full-year adjusted earnings guidance to a range of $7.90-$8.10 per share and increasing the cash flow from operations forecast to at least $11.50 billion.